1052
W. J. Spillane et al. / Tetrahedron Letters 49 (2008) 1049–1052
References and notes
11. McCaw, C. J. A.; Spillane, W. J. J. Phys. Org. Chem. 2006, 19, 512;
Spillane, W. J.; McGrath, P.; Brack, C.; O’Byrne, A. J. Org. Chem.
001, 66, 6313.
2
1
. (a) Maryanoff, B. E.; Nortey, S. O. U.S. Patent 4,792,569; (b)
Maryanoff, B. E. Chem. Abstr. 1989, 110, 212340; (c) Maryanoff, B.
E.; Nortey, S. O.; Gardocki, J. F.; Shank, R. P.; Dodgson, S. P. J.
Med. Chem. 1987, 30, 880.
1
2. (a) Thea, S.; Cevasco, G.; Guanti, G.; Williams, A. J. Chem. Soc.,
Chem. Commun. 1986, 1582; (b) Williams, A.; Douglas, K. T. J.
Chem. Soc., Perkin Trans. 2 1974, 1727; (c) Douglas, K. T.; Williams,
A. J. Chem. Soc., Chem. Commun. 1973, 2, 356.
2
3
4
5
. Fehr, T.; Stadler, P.; Stuetz, P. U.S. Patent 4,348,392; Fehr, T.;
Stadler, P. Chem. Abstr. 1983, 98, 54276.
. See: Jenkins, I. D.; Verheyden, J. P. H.; Moffatt, J. G. J. Am. Chem.
Soc. 1976, 98, 4436; and references cited therein.
. Castro-Pichel, J.; Garcia-Lopez, M. T.; De ls Heras, F. G. Tetra-
hedron 1987, 43, 383.
. Benson, G. A.; Spillane, W. J. In The Chemistry of Sulfonic Acids,
Esters and their Derivatives; Patai, S., Rappoport, Z., Eds.; John
Wiley & Sons Ltd: New York, 1991; pp 947–1036; for more examples.
. (a) Medical Pharmacology and Therapeutics; 2nd ed.; Waller, D. G.,
Renwick, A. G., Hillier, K., Eds.; Elsevier Saunders: London, 2005;
1
3. Denehy, E.; White, J. M.; Williams, S. J. J. Chem. Soc., Chem.
Commun. 2006, 314.
1
1
4. Burnett, J. R.; Huff, M. W. Curr. Opin. Invest. Drugs 2002, 3, 1328.
5. Okata, M.; Iwashita, S.; Koizumi, N. Tetrahedron Lett. 2000, 41,
7
047.
1
6. Patel, C. K.; Galisson, A.; James, K.; Owen, C. P.; Ahmed, S. Pharm.
Pharmacol. 2003, 55, 211.
1
1
7. Notley, J. M. J. Appl. Chem. Biotechnol. 1973, 23, 717.
8. Kevill, D. N.; Park, B.-C.; Park, K.-H.; D’Souza, M. J.; Yaakoubd,
L.; Mlynarski, S. L.; Kyong, J. B. Org. Biomol. Chem. 2004, 4, 1580.
9. Benkovic, S. J.; Benkovic, P. A. J. Am. Chem. Soc. 1966, 88, 5504.
0. Pryor, W. A.; Tonellato, U. J. Am. Chem. Soc. 1967, 89, 3379.
1. Spillane, W. J.; Malaubier, J.-B. Tetrahedron Lett. 2007, 48, 7574.
2. Koo, S. I.; Bentley, T. W.; Kang, D. H.; Lee, I. J. Chem. Soc., Perkin
Trans. 2 1991, 175.
6
1
2
2
2
(b) Maryanoff, B. E.; Costanzo, M. J.; Nortey, S. O.; Greco, M. N.;
Shank, R. P.; Schupsky, J. J.; Ortegon, M. P.; Vaught, J. L. J. Med.
Chem. 1998, 41, 1315.
7. Purohit, A.; Woo, L. W. L.; Barrow, D.; Hejaz, H. A. M.; Nicholson,
R. I.; Potter, B. V. L.; Reed, M. J. Mol. Cell. Endocrinol. 2001, 171,
2
3. Bentley, T. W.; Llewellyn, G.; McAlister, J. A. J. Org. Chem. 1996,
129.
6
1, 7927.
4. Bentley, T. W.; Llewellyn, G.; Ryu, Z. H. J. Org. Chem. 1998, 63,
654.
8
. Stanway, S. J.; Purohit, A.; Woo, L. W. L.; Sufi, S.; Vigushin, D.;
Ward, R.; Wilson, R. H.; Stanczyk, F. Z.; Dobbs, N.; Kulinskaya, E.;
Elliott, M.; Potter, B. V. L.; Reed, M. J.; Coombes, R. C. Clin. Cancer
Res. 2006, 12, 1585.
2
4
2
2
5. Lee, I.; Lee, B. C. J. Korean Chem. Soc. 1980, 24, 342.
6. Schowen, R. L. Mechanistic Deductions from Solvent Isotope Effects.
In Progress in Physical Organic Chemistry; Streitwieser, A., Taft, R.
W., Eds.; Wiley-Interscience: London, 1972; Vol. 9, pp 275–332.
7. Fedor, L. R.; Bruice, T. C. J. Am. Chem. Soc. 1965, 87, 4138.
8. Gopalakrishnan, G.; Hogg, J. L. J. Org. Chem. 1984, 49, 3161; and
references cited within.
9. Elger, W.; Schwarz, S.; Hedden, A.; Reddersen, G.; Schneider, B. J.
Steroid Biochem. Mol. Biol. 1995, 55, 395.
10. (a) Supuran, C. T.; Scozzafava, A. Bioorg. Med. Chem. 2007, 15,
2
2
4336; (b) Scozzafava, A.; Mastrolorenzo, A.; Supuran, C. T. Expert.
Opin. Ther. Pat. 2006, 16, 1627; (c) Reed, M. J.; Purohit, A.; Woo, L.
W. L.; Newman, S. P.; Potter, B. V. L. Endocrine Rev. 2005, 26, 171;
2
9. Paborji, M.; Waugh, W. N.; Stella, V. J. J. Pharm. Sci. 1987, 76,
(d) Winum, J.-Y.; Scozzafava, A.; Montero, J.-L.; Supuran, C. T.
1
61.
Med. Res. Rev. 2004, 25, 186.